Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Cavo

Showing results (1-10 of 506) with videos related to

Pageof 51
Sort By:
Haematologica|April 6, 2023
CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myelomaMichele Cavo
Blood|September 17, 2011
A third-generation IMiD for MMMichele Cavo
Blood|July 13, 2019
Facing lenalidomide-refractory myelomaMichele Cavo
Blood|January 30, 2016
Together for better?Michele Cavo
Current Hematologic Malignancy Reports|April 29, 2010
Current status of bortezomib in the treatment of multiple myelomaMichele Cavo
Blood|July 8, 2017
Toward a GEP-based PET in myelomaElena Zamagni, Michele Cavo
The New England Journal of Medicine|March 10, 2006
The changing landscape of myeloma therapyMichele Cavo, Michele Baccarani
British Journal of Haematology|August 14, 2012
The role of imaging techniques in the management of multiple myelomaElena Zamagni, Michele Cavo
Haematologica|March 1, 2002
Thalidomide in multiple myeloma: state of artPatrizia Tosi, Michele Cavo
Bone Marrow Transplantation|April 23, 2022
Prof. Sante Tura: father of modern Italian Haematology 20 May, 1929 to 12 October, 2021Michele Cavo, Robert Peter Gale
Pageof 51

Showing results (1-10 of 506) with videos related to

Sort By:
Pageof 51
Haematologica|April 6, 2023
CAR T-cell therapy for triple-class exposed relapsed/refractory multiple myelomaMichele Cavo
Blood|September 17, 2011
A third-generation IMiD for MMMichele Cavo
Blood|July 13, 2019
Facing lenalidomide-refractory myelomaMichele Cavo
Blood|January 30, 2016
Together for better?Michele Cavo
Current Hematologic Malignancy Reports|April 29, 2010
Current status of bortezomib in the treatment of multiple myelomaMichele Cavo
Blood|July 8, 2017
Toward a GEP-based PET in myelomaElena Zamagni, Michele Cavo
The New England Journal of Medicine|March 10, 2006
The changing landscape of myeloma therapyMichele Cavo, Michele Baccarani
British Journal of Haematology|August 14, 2012
The role of imaging techniques in the management of multiple myelomaElena Zamagni, Michele Cavo
Haematologica|March 1, 2002
Thalidomide in multiple myeloma: state of artPatrizia Tosi, Michele Cavo
Bone Marrow Transplantation|April 23, 2022
Prof. Sante Tura: father of modern Italian Haematology 20 May, 1929 to 12 October, 2021Michele Cavo, Robert Peter Gale
Pageof 51